Evidence map›Paper›PMID 17183014›Full record

ArticleJournal of epidemiology and community health2007

Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.

Jaume Marrugat, Isaac Subirana, Eva Comín, Carmen Cabezas, Joan Vila, Roberto Elosua, Byung-Ho Nam, Rafel Ramos, Joan Sala, Pascual Solanas and 4 more

Erratum issued 3 registry-linked trialsAbstract readValidation Study
In one paragraph

Article in Journal of epidemiology and community health, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 3 registered trials, which are not on this map. Cited by 59 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01428934 completednot on this mapstarted 2011, after this paper: background citation

Improving Intermediate Risk Management. MARK Study

TypeobservationalSponsorFundacio d'Investigacio en Atencio Primaria Jordi Gol i GurinaRan2011 to 2016Enrolled2,495ConditionsMyocardial Infarction, Angina Pectoris, Stroke, Peripheral Arterial Disease
NCT02261441 unknown statusnot on this mapstarted 2014, after this paper: background citation

Identificación de la poBlación Española de RIesgo CArdiovascular y reNal

TypeobservationalSponsorLa Sociedad Española de Médicos de Atención PrimariaRan2014 to 2019Enrolled15,000ConditionsCardiovascular DiseaseArmsObservational and noninterventional study
NCT02373319 nacompletednot on this mapstarted 2016, after this paper: background citation

Validity and Effectiveness of a Method for Self-screening of Cardiovascular Risk

TypeinterventionalSponsorParc de Salut MarRan2016 to 2018Enrolled960ConditionsRisk Factor, CardiovascularArmsCV-screening-1 plus personalized, CV-screening-2 plus personalized, CV-screening-1 plus standard, CV-screening-2 plus standard
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Atencion primaria · 2018
    Guideline
  4. Guideline
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Improving interMediAte risk management. MARK study.BMC cardiovascular disorders · 2011
    Trial
  11. Sex andInternational journal of molecular sciences · 2025
    Article
  12. Article
  13. Cohort Profile: The Girona Heart Registry.International journal of epidemiology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

14 authors.

Jaume MarrugatLípids and Cardiovascular Epidemiology Unit, Institut Municipal d'Investigació Mèdica (IMIM), Carrer Dr Aiguader, 88, 08003 Barcelona, Spain. jmarrugat@imim.es
Isaac Subirana
Eva Comín
Carmen Cabezas
Joan Vila
Roberto Elosua
Byung-Ho Nam
Rafel Ramos
Joan Sala
Pascual Solanas
Ferran Cordón
Joan Gené-Badia
Ralph B D'Agostino
VERIFICA Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo assess the reliability and accuracy of the Framingham coronary heart disease (CHD) risk function adapted by the Registre Gironí del Cor (REGICOR) investigators in Spain.

methodsA 5-year follow-up study was completed in 5732 participants aged 35-74 years. The adaptation consisted of using in the function the average population risk factor prevalence and the cumulative incidence observed in Spain instead of those from Framingham in a Cox proportional hazards model. Reliability and accuracy in estimating the observed cumulative incidence were tested with the area under the curve comparison and goodness-of-fit test, respectively.

resultsThe Kaplan-Meier CHD cumulative incidence during the follow-up was 4.0% in men and 1.7% in women. The original Framingham function and the REGICOR adapted estimates were 10.4% and 4.8%, and 3.6% and 2.0%, respectively. The REGICOR-adapted function's estimate did not differ from the observed cumulated incidence (goodness of fit in men, p = 0.078, in women, p = 0.256), whereas all the original Framingham function estimates differed significantly (p<0.001). Reliabilities of the original Framingham function and of the best Cox model fit with the study data were similar in men (area under the receiver operator characteristic curve 0.68 and 0.69, respectively, p = 0.273), whereas the best Cox model fitted better in women (0.73 and 0.81, respectively, p<0.001).

conclusionThe Framingham function adapted to local population characteristics accurately and reliably predicted the 5-year CHD risk for patients aged 35-74 years, in contrast with the original function, which consistently overestimated the actual risk.

Indexed as

AdultAgedCoronary DiseaseFemaleFollow-Up StudiesHumansIncidenceMaleMiddle AgedMyocardial InfarctionReproducibility of ResultsRisk AssessmentRisk FactorsSpain

Identifiers

PMID17183014
PMCPMC2465597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.